CompoAtlas

Cal-Mag Supreme

Natural health product licensed in Canada

Other names
Health First Cal Mag Supreme Tablets
Licence holder
Health First Network
NPN or DIN-HM
80091181
Status
Active licence
Licence date
13 March 2019
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Vitamine K2

Source : Ménaquinone 7

15 mcg30 µg
Vitamine D

Source : Cholécalciférol

Potency : 500 UI

12.5 mcg25 µg
Bore

Source : Citrate de bore

350 mcgNot calculated
Potassium

Source : Citrate de potassium

25 mg50,000 µg

Non-medicinal ingredients

Eau purifiée, Cellulose microcristalline, Stéarate de magnésium, Dioxyde de silicium colloïdal, Hydroxypropylméthylcellulose

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years2 Comprimé1 Tous les jours

Uses authorised in Canada

Calcium intake when combined with sufficient vitamin D, a healthy diet and regular exercise, may reduce the risk of developing osteoporosis. Helps in the development and maintenance of bones and teeth. Helps maintain proper muscle function. Helps to maintain healthy skin. Helps to maintain immune function. Helps in the absorption and use of calcium and phosphorous. Helps to maintain good health. Vitamin/Mineral Supplement.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80091181

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line